Budczies, Jan http://orcid.org/0000-0002-6668-5327
Kirchner, Martina
Kluck, Klaus
Kazdal, Daniel
Glade, Julia
Allgäuer, Michael
Kriegsmann, Mark
Heußel, Claus-Peter
Herth, Felix J.
Winter, Hauke
Meister, Michael
Muley, Thomas
Goldmann, Torsten
Fröhling, Stefan
Wermke, Martin
Waller, Cornelius F.
Tufman, Amanda
Reck, Martin
Peters, Solange
Schirmacher, Peter
Thomas, Michael
Christopoulos, Petros
Stenzinger, Albrecht
Funding for this research was provided by:
Deutsche Zentrum für Lungenforschung
Roche
Universitätsklinikum Heidelberg
Article History
Received: 5 December 2020
Accepted: 4 June 2021
First Online: 14 June 2021
Declarations
:
: Dr. Budczies reports grants from German Cancer Aid, outside the submitted work. Dr. Kirchner, Mr. Kluck, Ms. Glade, Dr. Allgäuer, Dr. Kriegsmann, Dr. Winter, Dr. Goldmann, Dr. Wermke have nothing to disclose. Dr. Kazdal reports personal fees from Pfizer Pharma GmbH, outside the submitted work. Dr. Herth reports personal fees from Schering-Plough, personal fees from Pfizer, personal fees from Basilea, personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Roche, personal fees from Astellas, personal fees from Gilead, personal fees from MSD, personal fees from Lilly, personal fees from Intermune, personal fees from Fresenius, personal fees from Essex, personal fees from AstraZeneca, personal fees from Bracco, personal fees from MEDA Pharma, personal fees from Chiesi, personal fees from Siemens, personal fees from Covidien, personal fees from Pierre Fabre, personal fees from Grifols, personal fees from Bayer, personal fees from Siemens, personal fees from Pfizer, personal fees from MeVis, personal fees from Boehringer Ingelheim, personal fees from German Cancer for Lung Research, outside the submitted work; In addition, Dr. Herth has a patent Method and Device For Representing the Microstructure of the Lungs. IPC8 Class: AA61B5055FI, PAN: 20080208038 pending. Dr. Herth reports personal fees from Schering-Plough, personal fees from Pfizer, personal fees from Basilea, personal fees from Boehringer Ingelheim, personal fees from Novartis, personal fees from Roche, personal fees from Astellas, personal fees from Gilead, personal fees from MSD, personal fees from Lilly, personal fees from Intermune, personal fees from Fresenius, personal fees from Essex, personal fees from AstraZeneca, personal fees from Bracco, personal fees from MEDA Pharma, personal fees from Chiesi, personal fees from Siemens, personal fees from Covidien, personal fees from Pierre Fabre, personal fees from Grifols, personal fees from Bayer, personal fees from Siemens, personal fees from Pfizer, personal fees from MeVis, personal fees from Boehringer Ingelheim, personal fees from German Cancer for Lung Research, outside the submitted work. Dr. Meister reports grants from German Center for Lung Research (DZL), during the conduct of the study. Dr. Muley reports grants and non-financial support from Roche Diagnostics GmbH, Penzberg, Germany, outside the submitted work; In addition, Dr. Muley has a patent WO2019158460 pending, a patent WO2019211418 pending, a patent WO2019215223 pending, a patent EP3391053 issued and a patent EP3365679 pending. Dr. Fröhling reports personal fees from Amgen, grants from AstraZeneca, personal fees from Bayer, personal fees from Eli Lilly, grants from Pfizer, grants and personal fees from PharmaMar, personal fees from Roche, outside the submitted work. Dr. Waller is a consultant/advisory board member for Mylan Inc. Dr. Reck reports personal fees from Amgen, personal fees from AstraZeneca, personal fees from BMS, personal fees from Boehringer Ingelheim, personal fees from Lilly, personal fees from Merck, personal fees from MSD, personal fees from Novartis, personal fees from Pfizer, personal fees from Roche, personal fees from Samsung, outside the submitted work. Dr. Peters reports personal fees from Abbvie, personal fees from Amgen, personal fees from AstraZeneca, personal fees from Bayer, personal fees from Biocartis, personal fees from Boehringer Ingelheim, personal fees from Bistrol-Myers Squibb, personal fees from Clovis, personal fees from Daiichi Sankyo, personal fees from Debiopharm, personal fees from Eli Lilly, personal fees from F. Hoffmann-La Roche, personal fees from Foundation Medicine, personal fees from Illumina, personal fees from Janssen, personal fees from Merck Sharp and Dohme, personal fees from Merck Serono, personal fees from Merrimack, personal fees from Novartis, personal fees from Pharma Mar, personal fees from Pfizer, personal fees from Regeneron, personal fees from Sanofi, personal fees from Seattle Genetics and Takeda, personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Bristol-Myers Squibb, personal fees from Eli Lilly, personal fees from F. Hoffmann-La Roche, personal fees from Merck Sharp and Dohme, personal fees from Novartis, personal fees from Pfizer, personal fees from Takeda, non-financial support from Sponsored by Amgen, non-financial support from AstraZeneca, non-financial support from Boehringer Ingelheim, non-financial support from Bristol-Meyers Squibb, non-financial support from Clovis, non-financial support from F. Hoffmann-La Roche, non-financial support from Illumina, non-financial support from Merck Sharp and Dohme, non-financial support from Merck Serono, non-financial support from Novartis, non-financial support from Pfizer, non-financial support from Sanofi, personal fees from Bioinvent, outside the submitted work. All fees to Institution. Dr. Schirmacher reports grants from QuIP, during the conduct of the study; grants and personal fees from BMS, grants and personal fees from MSD, grants and personal fees from Roche, grants and personal fees from AstraZeneca, grants and personal fees from Novartis, personal fees from Chugai, personal fees from AbbVie, grants from Sanofi-Aventis, personal fees from Ipsen, grants and personal fees from Pfizer, grants from Illumina, grants from Thermo Fisher, outside the submitted work. Dr. Thomas reports personal fees from AbbVie, grants, personal fees and non-financial support from BMS, personal fees and non-financial support from Boehringer, grants and personal fees from Celgene, personal fees from Lilly, personal fees and non-financial support from MSD, personal fees and non-financial support from Novartis, grants and personal fees from Roche, personal fees from Takeda, grants from AstraZeneca, outside the submitted work. Dr. Christopoulos reports grants and personal fees from Novartis, grants and personal fees from Roche, grants and personal fees from AstraZeneca, personal fees from Pfizer, grants and personal fees from Takeda, personal fees from Chugai, personal fees from Boehringer, outside the submitted work. Dr. Stenzinger reports personal fees from Astra Zeneca, grants and personal fees from Bayer, grants and personal fees from BMS, personal fees from MSD, personal fees from Takeda, personal fees from Seattle Genetics, grants from Chugai, personal fees from Novartis, personal fees from Illumina, personal fees from Thermo Fisher, personal fees from Eli Lily, personal fees from Takeda, outside the submitted work.